Rationale: Rigid bronchoscopy-guided (RBG) percutaneous tracheostomy has been used in patients with morbid obesity, prior neck surgery, distorted airway anatomy, and uncorrected coagulopathy where standard percutaneous dilational tracheostomy (PDT) is relatively contraindicated.
Tracheostomy is one of the most commonly performed procedures in the intensive care unit (ICU) (1, 2) . Since the introduction of percutaneous dilational tracheostomy (PDT) technique in 1985, substantial advances have been made, resulting in improved safety and ease of the procedure (3) . Over the past decade, the application of various imaging guidance modalities (flexible bronchoscopy, rigid bronchoscopy, and ultrasound) has further enhanced PDT and extended its use in a variety of patient populations (4, 5) .
In a recent European study, the majority of ICU physicians (73%) prefer to use PDT as the procedure of choice for elective tracheostomy in the ICU population requiring long-term ventilation (6) . A meta-analysis examining a pool of 1,000 patients noted several outcome differences between surgical tracheostomy and PDT (7) . Notably, there were fewer stomal wound infections, smaller neck scars, shorter procedural time, and reduction in cost with PDT. There were no significant differences in mortality, false passage creation, minor or major hemorrhage, or development of late subglottic stenosis between the techniques (3, 4, (7) (8) (9) (10) (11) .
PDT is easily performed through the use of the flexible or the rigid bronchoscope. However, unlike the rigid bronchoscope, the flexible bronchoscope does not provide a secure airway, can be damaged, does not provide protection to the posterior tracheal membrane, has limited suction capability, and obstructs the endotracheal tube, which may interfere with adequate ventilation. The use of rigid bronchoscopy in PDT has not been adequately described. In a review of the literature, only one case series of seven patients using rigid bronchoscopy has been reported (8) . Thus, a more in-depth evaluation of the use of rigid bronchoscopy-guided (RBG) PDT to assess the utility, practicality, and safety profile is needed. Here, we present our experience in the use of RBG-PDT at our institution in patients considered at high risk for percutaneous tracheostomy. Some of the results of our study have been previously reported in abstract form (12) and were presented at the May 2012 American Thoracic Society meeting in San Francisco.
Methods

Study Design and Patient Selection
We retrospectively collected all consecutive patients who underwent RGB-PDT from January 2008 to December 2012. The study protocol was approved by the institutional review board at Beth Israel Deaconess Medical Center, Boston, Massachusetts (Protocol 2011-P-000186).
The Beth Israel Deaconess Medical Center is a tertiary-care academic facility, with a medical, surgical, trauma, cardiac, cardiothoracic, and neurologic ICU, and has a large general medical and surgical service.
We included all adult patients, 18 years or older, who suffered from acute respiratory failure requiring endotracheal intubation and mechanical ventilation, and were selected for tracheostomy placement under rigid bronchoscopy guidance for prolonged respiratory failure and failure to wean from mechanical ventilation. Patient medical records were reviewed for general demographics, comorbid medical conditions, American Society of Anesthesiology classification, indication for tracheostomy (specifically for RBG-PDT), duration of procedure, and periprocedural complications. Highrisk features, such as morbid obesity, coagulopathy, complex airway and prior neck surgery, were used for patient selection.
RBG-PDT
RBG-PDT is an elective procedure in our institution for medical and surgical patients with respiratory failure requiring tracheostomy to receive prolonged mechanical ventilatory support. Interventional pulmonologists and thoracic surgeons performed all the RBG-PDT procedures. All RBG-PDTs were performed in the operating room under general anesthesia and were monitored with continuous recording for heart rate, respiratory rate, blood pressure, oxygen saturation, and cardiac rhythm. Mechanical ventilation was maintained with fraction of inspired oxygen at 1.0 and jet ventilation.
After informed consent was obtained, the patient was brought to the operating room and placed in the supine position. A towel roll was placed between the scapulae to extend the neck. A 12-mm outer diameter rigid tracheoscope (Bryan-Dumon, Bryant Corp., Woburn, MA) was introduced orally ( Figure 1A ) and advanced to the posterior pharynx until the vocal cords were visualized. At that point, the rigid barrel was advanced to the glottis with the bevel anteriorly. The tip of the barrel was positioned 5 mm distal to the true vocal cords, and care was exercised to avoid displacement of the rigid barrel while removing the endotracheal tube from the airway ( Figure 1B ). The rigid tracheoscope was advanced into the subglottic area and was used to provide jet ventilation, continuous suction, and visual guidance for the remainder of the procedure ( Figure 1C ). After completing the exchange of the endotracheal tube for the rigid bronchoscope, the thyroid and cricoid cartilages were palpated. The tracheal rings could also be palpated and a mark was made at the second intercartilaginous space. The skin was prepped in the usual sterile fashion, and 10 ml of lidocaine (1.5%) with epinephrine (1:200,000 dilution) was used to anesthetize the skin and subcutaneous tissue. A 1-cm horizontal or vertical incision was performed. Through the incision, the Kelly clamp was used to dissect through the subcutaneous tissue to the anterior tracheal wall. At this point, the finder needle was introduced through the trachea and into the airway, and position was confirmed under bronchoscopic guidance. The guiding angiocath was then inserted between the second and third cartilaginous rings under bronchoscopic visualization. The needle was removed and the guide wire was introduced through the angiocath, followed by withdrawal of the angiocath. A punch dilator was introduced over the guide wire followed by the Blue Rhino (Cook Critical Care, Bloomington, IN) tapered dilator, which dilated the tracheal stoma. Then, a no. 7 or no. 8 Portex tracheostomy tube (Portex Per-fit; Smiths Medical, Dublin, OH) was introduced onto a dilator and advanced into the trachea. Both the dilator and wire were withdrawn, and the tracheostomy tube was secured in place with 2-0 Prolene sutures (Prolypropylene Suture, ETHICON; Johnson & Johnson, San Lorenzo, PR) on both sides ( Figure 1D ).
Results
A total of 35 patients underwent RGB percutaneous tracheostomy placement in a 5-year period. These patients consisted of 24 men with a mean age of 66 (611) years (range, 42-88 yr). The mean body mass index was 34 (68) kg/m 2 , whereas 16 patients had a body mass index greater than 35 kg/m 2 . The majority of patients (27 of 35) had an American Society of Anesthesiology classification of 4. The most common respiratory condition was failure to wean from mechanical ventilation, followed by tracheal stenosis and tracheobronchomalacia. The most commonly recorded indications for RGB-PDT were complex airway (history of difficult intubation and/or central airway obstruction), obesity, and coagulopathy. The mean procedure time was 32 (610) minutes, with a median of 33 minutes. Two patients had bleeding quantified as greater than 10 ml, but less than 50 ml. These bleeding episodes were controlled with suction and local application of epinephrine. Two patients experienced transient loss of the airway during the endotracheal tube-rigid bronchoscope exchange process; however, airway control was quickly re-established without associated hypoxemia. No major periprocedural complications or mortality was associated with the procedure. All procedures were considered successful ( Table 1 , Table E1 ).
Discussion
Percutaneous tracheostomy is a well recognized technique for establishing a long-term secure airway in the management of chronic respiratory failure that often occurs in the ICU patient population (2, 10, (13) (14) (15) . Complications associated with this procedure include bleeding (external or intratracheal), false airway passage, perforation of the posterior wall, placement of high or low tracheal stomas, displacement of tracheal stents, and resultant airway obstruction. Flexible bronchoscopy guidance is commonly performed to ensure the correct placement of the tracheostomy and to identify potential immediate complications (16) (17) (18) (19) . However, flexible bronchoscopy-guided PDT has inherent limitations. These include inadequate ventilation due to occlusion of the endotracheal tube, inadvertent puncture of the cuff or the flexible bronchoscope, inability to provide adequate suction in case of massive bleed, and loss of the airway in the attempt to show the operator the adequate puncture site (20) (21) (22) (23) . In a recent report, these limitations were circumvented with suspension laryngoscopy-assisted PDT (SL-PDT) (24) . There has been one report of rigid bronchoscope guidance in performing percutaneous tracheostomy (8) . Our study represents the largest case series to date demonstrating the safety profile and effectiveness of RBG-PDT in a highly selected patient population previously considered to have relative contraindications for PDT.
Similar to SL-PDT, we find that RBG percutaneous tracheostomy is most appropriate for patients who are morbidly obese, or have a complex airway, coagulopathy, or a history of prior surgery or radiation to the neck region. Both procedures (SL-PDT and RBG-PDT) provide improved visualization of the extratracheal operative field, control for any endotracheal bleeding, ventilation during the procedure, and exposure of the subglottic space and proximal trachea for accurate tracheostomy insertion and airway management. The major differences are the setup of the Pilling-Weck Louie arm suspension apparatus (Pilling-Weck Surgical, Fort Washington, PA), the use of 9.0-mm endotracheal tube with a 5-mm 30 8 Storz rigid endoscope (Karl Stortz Endoscopy, Tuttlingen, Germany) and a Dedo laryngoscope (Pilling Surgical, Horsham, PA) for the SL-PDT (24).
Patient's body habitus can be a hindrance to tracheostomy placement (25) . Rigid bronchoscopy not only offers excellent visibility during the procedure, but also displaces the trachea anteriorly to ease the access to the anterior tracheal wall and improve exposure to the puncture site. In patients with a complex airway, the rigid bronchoscope aids in maintaining a secure airway with the added ability to provide endobronchial interventions. A recent study showed that flexible PDT is safe to perform in patients with obesity. However, though statistically not significant, the patients who were morbidly obese did have double the bleeding risk when compared with the nonobese group (26) . During our initial experience, two patients experienced transient loss of the airway while the endotracheal tube was being exchanged for the rigid bronchoscope. Both patients were easily intubated with the rigid bronchoscope without associated hypoxemia. To prevent this complication, we modified the technique by positioning the tip of the barrel 5 mm distal to the true vocal cords in the subglottic space and avoiding displacement of the rigid barrel as the endotracheal tube is removed from the airway. Since this modification, we have not experienced any additional loss of airway during the procedure.
In those patients who have uncorrectable coagulopathy, secondary to liver failure, bone marrow suppression, or clopidogrel use, the large-caliber size of the rigid bronchoscope allows for the use of interventional modalities (suction, cauterization, epinephrine injections) in case of excessive bleeding. In our cohort, two patients had bleeding that was easily controlled with suction and epinephrine.
In patients with central airway obstruction, such as in the case of tracheal or subglottic stenosis, external compression, or tracheobronchomalacia, the airways are dilated and stented open by the rigid bronchoscope. This facilitates the procedure and prevents potential catastrophic complications, such as perforation of the 
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posterior membranous wall. Those patients with prior surgeries or radiation to the neck region may have altered anatomy due to scar tissue or strictures, thus requiring better exposure of the anterior tracheal wall to minimize the risk of extending the primary stenotic segment. In our series, we did not observe any increase in postoperative complications or airway compromise with concurrent RBG-PDT and treatment of tracheal obstructive lesions. In addition, by addressing central airway lesions with RBG-PDT, we are able to offer a less invasive (potentially more cost effective) approach than the surgical option involving tracheal resection, which is often avoided in patients with respiratory failure.
There are potential obstacles to widely adopting this procedure. First, this procedure requires familiarity with operating a rigid bronchoscope. Second, it requires transport of the patient from the ICU to the operating room. Third, if not performed by experienced operators, the airway can be lost during the exchange process. Fourth, rigid bronchoscopy may not be adaptive to a bedside procedure in many institutions (27) (Table 2) .
Nevertheless, in the appropriate patient population, rigid bronchoscopy offers many advantages. First, it supports the softer structures, reducing the risk of tracheoesophageal puncture and fistula formation. Second, anterior leverage of the trachea facilitates tracheal cannulation, especially in patients who are obese. Third, in the cases of previously placed tracheal stents, the rigid bronchoscope provides a large visual field and minimizes the chance for dislodgement or compression of the stents. Furthermore, in patients with complex airways, the rigid bronchoscope provides a secure airway with excellent views without risk of cuff puncture or inadvertent dislodgement of the endotracheal tube (28) . Finally, in patients with coagulopathy, the rigid bronchoscope allows easy hemostatic control. Based on these data, we propose an algorithm for selection of appropriate patients for RGB-PDT ( Figure 2) .
It is important to note that, out of a total 360 percutaneous tracheostomies performed in the study period, only 35 patients (,10%) underwent RGB-PDT. We were very selective, especially with patients who were morbidly obese. Contrary to the prior reports on the significant complications of PDT in patients who were morbidly obese (29), we observed a 6.5% complication rate similar to that reported by Heyrosa and colleagues (30) . The issue of poor anatomical landmarks in the patient who is morbidly obese is reduced with the use of rigid bronchoscopy.
The major limitation in our study was the lack of direct comparison between RBG-PDT and that of flexible bronchoscopyguided PDT. Thus, we are unable to prove a benefit of using the rigid bronchoscope in PDT. However, we do provide the setup and feasibility for future investigations involving use of the rigid bronchoscope in a specified high-risk population. The superiority in using rigid bronchoscopic guidance can only be definitely addressed with future randomized controlled clinical trials. Another limitation in our study is the lack of cost-effectiveness analysis. However, based on previous studies comparing (7, 31) . The third limitation of our current setup involves transporting of patients to the operating room. Although prior studies have reported that transport of critically ill patients can carry a risk of significant adverse events ranging from 4 to 8% (32), we did not observe any complications related to transportation. Fourth, the need of a well trained bronchoscopist to use rigid bronchoscopy can limit the availability of the procedure. However, in the last decade, rigid bronchoscopy has been gaining popularity, largely due to the increasing numbers of practicing interventional pulmonologists. In the near future, the procedures involving the use of rigid bronchoscopy are projected to be more widespread. Finally, the learning period for PDT is shorter than for surgical tracheostomy (33) . This may favorably impact the implementation of RBG-PDT in patients previously considered at high risk for percutaneous approach.
Our study offers a single-center experience with RBG-PDT, not as a replacement, but, rather, as an adjunct to the current spectrum of available care, which includes FBG-PDT, SL-PDT, and open tracheostomy. To truly demonstrate the value of RBG-PDT, future randomized clinical trials are needed to compare the RBG-PDT to the current standard of care in terms of safety, indications, and cost effectiveness. In the largest case series to date, we demonstrate that RBG-PDT is safe and effective when performed by experienced bronchoscopists in a population of high-risk patients who are otherwise not considered good candidates for standard PDT. As an intermediate step between percutaneous and surgical tracheostomy, we propose a strategy to incorporate rigid bronchoscope use in PDT for a selected patient population with morbid obesity, complex airways, and/or coagulopathy. n Author disclosures are available with the text of this article at www.atsjournals.org.
